The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The long noncoding RNA HORAS5
mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program
Authors
Keywords
-
Journal
Molecular Oncology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-02-19
DOI
10.1002/1878-0261.12471
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BART: bioinformatics array research tool
- (2018) Maria Luisa Amaral et al. BMC BIOINFORMATICS
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis
- (2016) Yuan Wang et al. CANCER LETTERS
- BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer
- (2016) Iris Sze Ue Luk et al. CLINICAL CANCER RESEARCH
- The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer
- (2016) Greg L. Shaw et al. EUROPEAN UROLOGY
- The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer
- (2016) Francesco Crea et al. Epigenomics
- The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo
- (2015) Abhijit Parolia et al. Molecular Cancer
- The landscape of long noncoding RNAs in the human transcriptome
- (2015) Matthew K Iyer et al. NATURE GENETICS
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer
- (2015) Ali Zhang et al. Cell Reports
- Three-dimensional regulation of transcription
- (2015) Jun Cao et al. Protein & Cell
- GATA2 as a potential metastasis-driving gene in prostate cancer
- (2015) Yan Ting Chiang et al. Oncotarget
- Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer
- (2015) Ehsan Malek et al. Oncotarget
- Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer
- (2015) Francesco Crea et al. Oncotarget
- Next generation patient-derived prostate cancer xenograft models
- (2014) Yuzhuo Wang et al. ASIAN JOURNAL OF ANDROLOGY
- The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer
- (2014) T Hemdan et al. BRITISH JOURNAL OF CANCER
- Androgen receptor signaling in prostate cancer
- (2014) Zoran Culig et al. CANCER AND METASTASIS REVIEWS
- A Combined Transgenic Proteomic Analysis and Regulated Trafficking of Neuroligin-2
- (2014) Yunhee Kang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Long Noncoding RNAs as Putative Biomarkers for Prostate Cancer Detection
- (2014) Bongyong Lee et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer
- (2014) Wei Nie et al. LABORATORY INVESTIGATION
- Long non-coding RNAs in cancer invasion and metastasis
- (2014) Xiao-han Shen et al. MODERN PATHOLOGY
- Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement
- (2014) Bruce J. Walker et al. PLoS One
- Physiological roles of long noncoding RNAs: insight from knockout mice
- (2014) Lingjie Li et al. TRENDS IN CELL BIOLOGY
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
- (2014) M. Hidalgo et al. Cancer Discovery
- High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
- (2013) D. Lin et al. CANCER RESEARCH
- Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models
- (2013) D. Siolas et al. CANCER RESEARCH
- A Novel Antiandrogen, Compound 30, Suppresses Castration-Resistant and MDV3100-Resistant Prostate Cancer Growth In Vitro and In Vivo
- (2013) H. Kuruma et al. MOLECULAR CANCER THERAPEUTICS
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
- (2013) T Karantanos et al. ONCOGENE
- Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy
- (2013) Lei Yan et al. PLoS One
- Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
- (2013) Lina Gao et al. PLoS One
- Elevated KIAA0101 expression is a marker of recurrence in human gastric cancer
- (2012) Kun Zhu et al. CANCER SCIENCE
- Correlation of proteome-wide changes with social immunity behaviors provides insight into resistance to the parasitic mite, Varroa destructor, in the honey bee (Apis mellifera)
- (2012) Robert Parker et al. GENOME BIOLOGY
- Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression
- (2011) John R Prensner et al. NATURE BIOTECHNOLOGY
- Proliferating cell nuclear antigen (PCNA)-associated KIAA0101/PAF15 protein is a cell cycle-regulated anaphase-promoting complex/cyclosome substrate
- (2011) M. J. Emanuele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics
- (2009) Jürgen Cox et al. Nature Protocols
- Tissue culture media supplemented with 10% fetal calf serum contains a castrate level of testosterone
- (2009) J.P. Michiel Sedelaar et al. PROSTATE
- A Novel RNA Transcript with Antiapoptotic Function Is Silenced in Fragile X Syndrome
- (2008) Ahmad M. Khalil et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started